Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Early Capture Threshold Dynamics Following Helix-Fixation Atrial Leadless Pacemaker Implantation.

Heart rhythm·2026

Same author

Pulsed Field Ablation as Initial Therapy for Persistent Atrial Fibrillation.

The New England journal of medicine·2026

Same author

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation.

The New England journal of medicine·2026

Same author

Social Drivers of Health in Heart Failure Trials: An Analysis From the Heart Failure Collaboratory.

JACC. Heart failure·2025

Same author

Quantitative bead-based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples.

Frontiers in immunology·2025

Same author

Real-world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry.

ESC heart failure·2024

Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026

Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026

Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026

Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026

Same journal

Beyond the ICD: Navigating Ventricular Tachycardia Suppression Strategies in the Modern Era.

Current cardiology reports·2026

Same journal

Updates on Pathophysiology of Pericarditis to Guide Development of Therapeutics.

Current cardiology reports·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Selective site pacing: rationale and practical application.

Sameer Parekh¹, Kenneth M Stein

¹Division of Cardiology, Cornell University Medical Center, 520 East 70th Street, Starr-4, New York, NY 10065, USA.

Current Cardiology Reports

|August 22, 2008

Summary

This summary is machine-generated.

Traditional pacemaker placement may cause adverse effects. New research explores alternative pacing sites in the right ventricle and atrium, potentially improving patient outcomes by mimicking natural heart rhythms.

More Related Videos

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Published on: November 7, 2019

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

Related Experiment Videos

Last Updated: Jul 2, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Published on: November 7, 2019

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

Area of Science:

Cardiovascular Electrophysiology
Cardiac Pacing Technology

Background:

Conventional pacemaker lead placement at the right ventricular apex and right atrial appendage is standard but does not replicate normal cardiac physiology.
Right ventricular apical pacing is associated with ventricular dyssynchrony and adverse effects, prompting investigation into alternative strategies.

Purpose of the Study:

To evaluate the efficacy of selective site pacing in the right ventricle and atrium compared to traditional locations.
To explore novel pacing strategies that better mimic physiological cardiac activation.

Main Methods:

Review of early trial data and ongoing large-scale randomized clinical trials.
Investigation of alternative right ventricular pacing sites including His bundle, para-Hisian, septal right ventricular outflow tract, and midseptal pacing.
Assessment of right atrial pacing near Bachmann's bundle versus the right atrial appendage.

Main Results:

Early data suggest that alternative right ventricular pacing sites may yield improved outcomes.
Preliminary findings indicate that right atrial pacing near Bachmann's bundle might offer superior results compared to the right atrial appendage.

Conclusions:

Selective site pacing represents a promising advancement over traditional pacemaker lead placement.
Further large-scale randomized trials are necessary to confirm the benefits and establish the role of selective site pacing in clinical practice.